Back

Non-invasive Preimplantation Genetic Testing of Embryonic Genome in Spent Culture Medium

Huang, L.; Zou, Y.; Zhang, R.; Huang, J.; Ying, G.; Wang, Q.; Xia, Y.; Jia, J.; Wu, Z.; Cao, D.; Song, W.; Tang, Y.; Liu, K.; Chai, X.; Chen, G.-B.; Lu, S.; Ge, H.; Qiao, J.; Xie, X. S.

2024-11-13 genetic and genomic medicine
10.1101/2024.11.10.24317049 medRxiv
Show abstract

Traditionally, preimplantation genetic testing (PGT) for in vitro fertilization (IVF) requires invasive trophectoderm (TE) biopsy, which might be detrimental to the embryo. Recently proposed non-invasive PGT (ni-PGT) utilizing cell-free DNA from spent embryo culture medium (SCM) also faces serious challenges in accuracy, especially for monogenic diseases (niPGT-M), due to trace DNA content, maternal cell contamination, and high Allele Drop-Out (ADO) rates. In this study, an improved linear single-cell whole genome amplification method and a Bayesian linkage analysis model were used to enhance accuracy in niPGT-M. We achieved about 75% report rate across all samples and 100% accuracy in the reported samples. Meanwhile, we reconstructed the embryonic genome and calculated the risk of type II diabetes (T2D) via niPGT-P, consistent well with those from TE biopsy samples. Our approach alleviated the limitations of ni-PGT and offers a promising avenue for advancing noninvasive PGT with potential clinical applications.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.